Growth Metrics

ENDRA Life Sciences (NDRA) Non-Current Debt: 2020-2021

Historic Non-Current Debt for ENDRA Life Sciences (NDRA) over the last 2 years, with Sep 2021 value amounting to $581,314.

  • ENDRA Life Sciences' Non-Current Debt rose 72.45% to $581,314 in Q3 2021 from the same period last year, while for Sep 2021 it was $581,314, marking a year-over-year increase of 72.45%. This contributed to the annual value of $337,084 for FY2020, which is N/A change from last year.
  • ENDRA Life Sciences' Non-Current Debt amounted to $581,314 in Q3 2021, which was down 5.43% from $614,677 recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Non-Current Debt ranged from a high of $614,677 in Q2 2021 and a low of $28,484 during Q1 2021.
  • For the 2-year period, ENDRA Life Sciences' Non-Current Debt averaged around $372,621, with its median value being $337,084 (2020).
  • Data for ENDRA Life Sciences' Non-Current Debt shows a peak YoY spiked of 82.35% (in 2021) over the last 5 years.
  • Over the past 2 years, ENDRA Life Sciences' Non-Current Debt (Quarterly) stood at $337,084 in 2020, then surged by 72.45% to $581,314 in 2021.
  • Its Non-Current Debt stands at $581,314 for Q3 2021, versus $614,677 for Q2 2021 and $28,484 for Q1 2021.